Cargando…
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy
There is an urgent need to identify efficient antiviral compounds to combat existing and emerging RNA virus infections, particularly those related to seasonal and pandemic influenza outbreaks. While inhibitors of the influenza viral integral membrane proton channel protein (M2), neuraminidase (NA),...
Autores principales: | Marsili, Giulia, Acchioni, Chiara, Remoli, Anna Lisa, Amatore, Donatella, Sgarbanti, Rossella, De Angelis, Marta, Orsatti, Roberto, Acchioni, Marta, Astolfi, Andrea, Iraci, Nunzio, Puzelli, Simona, Facchini, Marzia, Perrotti, Edvige, Cecchetti, Violetta, Sabatini, Stefano, Superti, Fabiana, Agamennone, Mariangela, Barreca, Maria Letizia, Hiscott, John, Nencioni, Lucia, Sgarbanti, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341698/ https://www.ncbi.nlm.nih.gov/pubmed/37445672 http://dx.doi.org/10.3390/ijms241310495 |
Ejemplares similares
-
IκB kinase-ε-mediated phosphorylation triggers IRF-1 degradation in breast cancer cells
por: Remoli, Anna Lisa, et al.
Publicado: (2020) -
HIV-1 Tat Recruits HDM2 E3 Ligase To Target IRF-1 for Ubiquitination and Proteasomal Degradation
por: Remoli, Anna Lisa, et al.
Publicado: (2016) -
Fighting HIV-1 Persistence: At the Crossroads of “Shoc-K and B-Lock”
por: Acchioni, Chiara, et al.
Publicado: (2021) -
p38α MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening
por: Astolfi, Andrea, et al.
Publicado: (2015) -
Pharmacological Agents Targeting the Cellular Prion Protein
por: Barreca, Maria Letizia, et al.
Publicado: (2018)